Biopharmaceutical company, Aegerion Pharmaceuticals, Inc. announced that Japan's Ministry of Health, Labor & Welfare (MHLW) has approved Juxtapid for patients with homozygous familial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback